Pfizer Unit's Skelaxin Pay-For-Delay Deal Illegal: Suit
Two pharmacies hit Pfizer Inc. unit King Pharmaceuticals Inc. with a proposed competition class action Wednesday in Tennessee, alleging that they paid inflated prices for the muscle relaxant Skelaxin because King...To view the full article, register now.
Already a subscriber? Click here to view full article